Back
Atara Biotherapeutics Stock Predictions
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
ATRA
Atara Biotherapeutics
Last Price:
$6.91
Seasonality Move:
-15.4%
7 Day Trial
ALL ACCESS PASS
$
7
Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Atara Biotherapeutics Stock Forecast
-
Over the next 52 weeks, Atara Biotherapeutics has on average historically fallen by 17.4% based on the past 10 years of stock performance.
-
Atara Biotherapeutics has fallen lower in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
-
Is Atara Biotherapeutics Stock Undervalued?The current Atara Biotherapeutics [ATRA] share price is $7.17. The Score for ATRA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
ATRA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Atara Biotherapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Atara Biotherapeutics has on average historically fallen by 17.4% based on the past 10 years of stock performance.
Atara Biotherapeutics Stock Rating
Sell
20
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics overpriced?
-
Atara Biotherapeutics has fallen lower in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Atara Biotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
atarabio.com
52-Week Data
52-Week High:
20.81
52-Week Low:
5.40
Prediction Charts
Market Cap:
42M
Price in USD:
7.17
Volume:
49.9K
Beta:
0.99
Technical Analysis
SMA50:
9.39
SMA100:
10.22
SMA200:
9.77
52-Wk Change:
-53.8%
Stock Predictions
-
Is Atara Biotherapeutics stock public?Yes, Atara Biotherapeutics is a publicly traded company.
-
What is the Atara Biotherapeutics stock quote today?The Atara Biotherapeutics stock price is 7.17 USD today.
-
How to buy Atara Biotherapeutics stock online?You can buy Atara Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-25 | 7.20 | 7.34 | 7.45 | 6.96 |
| Feb-26 | 7.36 | 7.39 | 7.70 | 7.30 |
| Feb-27 | 7.43 | 6.89 | 7.54 | 6.87 |
| Feb-28 | 6.82 | 6.92 | 7.01 | 6.55 |
| Mar-3 | 6.92 | 7.01 | 7.14 | 6.82 |
| Mar-4 | 6.95 | 7.07 | 7.42 | 6.61 |
| Mar-5 | 7.15 | 7.31 | 7.43 | 6.62 |
| Mar-6 | 7.20 | 6.80 | 7.20 | 6.79 |
| Mar-7 | 6.80 | 6.90 | 7.08 | 6.70 |
| Mar-11 | 6.24 | 6.61 | 6.89 | 5.94 |
| Mar-12 | 6.70 | 6.89 | 7.02 | 6.61 |
| Mar-13 | 6.80 | 6.86 | 6.99 | 6.67 |
| Mar-14 | 6.97 | 7.25 | 7.25 | 6.67 |
| Mar-17 | 7.20 | 7.17 | 7.60 | 7.17 |
Atara Biotherapeutics Earnings
Atara Biotherapeutics Earnings Report: Per Share Atara Biotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Atara Biotherapeutics Forecast Revenue Growth
Atara Biotherapeutics Stock Analysis: Historical quarterly revenues per share for Atara Biotherapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $2.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.60 per share, and an increase next year of $4.98 per share.
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.